tirzepatide and thyroid issues Cancer: UK Evidence and Safety Guidance Tirzepatide linked to thyroid problems

This data compared the effects of GLP-1 medications to other second-line diabetes treatments including dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and sulfonylureas

These outcomes were assessed using validated questionnaires, including the Binge Eating Scale (BES), Three-Factor Eating Questionnaire (TFEQ), and Statistical techniques were applied to calculate standardized mean differences, enabling comparison across studies with different scales

Caroline Apovian, MD, co-director of the Center for Weight Management and Wellness, says semaglutide and other therapies hold promise for people with obesityif only they were more accessible

Practical Applications for High-Risk Groups Semaglutide is especially beneficial for individuals at high risk for obesity-related cancers